Category: AHIP Letters

Dear New York Times: The Public Deserves Greater Transparency With Drug Prices

In response to a recent op-ed in the New York Times about expanding access to hepatitis C treatment, AHIP EVP Dan Durham addressed the real issue putting medicines out of reach for patients – skyrocketing launch prices being charged by drug companies. Continue reading

Posted in: AHIP in the News, AHIP Letters

Using mHealth to provide value to Medicaid members

Mobile technology is a valuable resource for health plans to connect with Medicaid beneficiaries. Through text notifications from their health plans, beneficiaries stay informed about preventive and ongoing care and receive convenient reminders about proactive steps they can take to improve their overall health and well-being. Continue reading

Posted in: AHIP Letters, Uncategorized

Stakeholders agree: We need generic competition

Recent proposals to extend market exclusivity for brand-name medications would delay generic competition and have a dangerous effect on pharmaceutical costs – pushing prices higher and higher. Continue reading

Posted in: AHIP Letters, Health Care Costs

Striking down weak patents protects patients

In some cases, explosive drug prices are the result of drugmakers’ patent schemes that financially distress consumers and limit their treatment options. That is why a recent proposal to exempt pharmaceutical companies from a key consumer protection would leave families across the country even more hostage to egregious pharmaceutical prices. Continue reading

Posted in: AHIP Letters, Cost Alert

Don’t Mess with the IPR

When pharmaceutical companies artificially prolong drug patents to avoid competition from generics, consumers end up with fewer treatment options and higher costs. These latest patent abuses demonstrate the need for strong oversight of drugmakers’ monopoly pricing schemes. Continue reading

Posted in: AHIP Letters, Issue Alert

AHIP Requests Additional Time to Submit Exchange Applications

America’s Health Insurance Plans’ (AHIP) President and CEO Karen Ignagni today sent a letter to CMS urging the agency to extend the deadline for submitting applications for the federally facilitated exchange. Continue reading

Posted in: AHIP, AHIP Letters

AHIP Comment Letters on ACA Regulations

AHIP recently submitted comment letters on several proposed ACA regulations released by the U.S. Department of Health and Human Services (HHS). Continue reading

Posted in: ACA, AHIP, AHIP Letters

AHIP’s Letter to HHS on the Essential Health Benefits’ Bulletin

Earlier today, AHIP submitted a comment letter to HHS in response to the Essential Health Benefits Bulletin released on December 16, 2011. AHIP’s comments strongly emphasize the need to assure an affordable EHB benefit package that promotes access to high-quality and cost-effective care for patients and consumers. Continue reading

Posted in: ACA, AHIP, AHIP Letters, Issue Alert

Karen Ignagni Letter to the Editor (New York Times)

Karen Ignagni’s letter to the editor appeared in the New York Times, Saturday, December 9, 2011 – “Any comparison between Medicare Advantage and fee-for-service Medicare must acknowledge the fact that Medicare Advantage plans provide more and better benefits.” Continue reading

Posted in: AHIP Letters

AHIP Submits Comments to HHS on the Proposed Rule for Exchanges

AHIP submitted comments to HHS yesterday on the proposed rule for the establishment of health insurance exchanges. Continue reading

Posted in: ACA, AHIP, AHIP Letters, Issue Alert